[{"address1": "Tower 11", "address2": "Level 10, Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Brian  Schwartz M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 53000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "CEO, President & Executive Director", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.229, "open": 0.234, "dayLow": 0.2263, "dayHigh": 0.2986, "regularMarketPreviousClose": 0.229, "regularMarketOpen": 0.234, "regularMarketDayLow": 0.2263, "regularMarketDayHigh": 0.2986, "payoutRatio": 0.0, "beta": 0.155, "forwardPE": -0.13994974, "volume": 3692808, "regularMarketVolume": 3692808, "averageVolume": 343880, "averageVolume10days": 533770, "averageDailyVolume10Day": 533770, "bid": 0.2746, "ask": 0.0, "bidSize": 11, "askSize": 0, "marketCap": 57743076, "fiftyTwoWeekLow": 0.17, "fiftyTwoWeekHigh": 4.0, "priceToSalesTrailing12Months": 1342.8622, "fiftyDayAverage": 0.2878, "twoHundredDayAverage": 0.68935, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 54606184, "profitMargins": 0.0, "floatShares": 12707647, "sharesOutstanding": 207336000, "sharesShort": 55680, "sharesShortPriorMonth": 182819, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.93925005, "heldPercentInstitutions": 0.0035100002, "shortRatio": 0.25, "shortPercentOfFloat": 0.0044, "impliedSharesOutstanding": 207336000, "bookValue": -0.245, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11212000, "trailingEps": -2.09, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1702857600, "enterpriseToRevenue": 1269.911, "enterpriseToEbitda": -4.551, "52WeekChange": -0.7941176, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 0.2785, "recommendationKey": "none", "totalCash": 3137000, "totalCashPerShare": 0.015, "ebitda": -11998000, "totalDebt": 0, "quickRatio": 0.5, "currentRatio": 0.586, "totalRevenue": 43000, "revenuePerShare": 0.008, "returnOnAssets": -1.16327, "grossProfits": 43000, "freeCashflow": -5268500, "operatingCashflow": -7990000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -279.16278, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 21.615715, "regularMarketPrice": 0.2785, "corporateActions": [], "postMarketTime": 1745625079, "regularMarketTime": 1745611202, "marketState": "CLOSED", "dividendDate": 1586908800, "earningsTimestamp": 1743624300, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.09, "epsForward": -1.99, "fiftyDayAverageChange": -0.009300023, "fiftyDayAverageChangePercent": -0.032314185, "twoHundredDayAverageChange": -0.41085002, "twoHundredDayAverageChangePercent": -0.59599626, "priceToBook": -1.1367346, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 0.394974, "postMarketPrice": 0.2796, "postMarketChange": 0.0011, "regularMarketChange": 0.04949999, "regularMarketDayRange": "0.2263 - 0.2986", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 343880, "fiftyTwoWeekLowChange": 0.10849999, "fiftyTwoWeekLowChangePercent": 0.6382352, "fiftyTwoWeekRange": "0.17 - 4.0", "fiftyTwoWeekHighChange": -3.7215, "fiftyTwoWeekHighChangePercent": -0.930375, "fiftyTwoWeekChangePercent": -79.411766, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]